Repurposing of Clinically Approved Poly-(ADP-Ribose) Polymerase Inhibitors for the Therapy of Sepsis.

Santos, Sidnéia Sousa; Brunialti, Milena Karina Colo; Soriano, Francisco Garcia; Szabo, Csaba; Salomão, Reinaldo

Santos, Sidnéia Sousa; Brunialti, Milena Karina Colo; Soriano, Francisco Garcia; Szabo, Csaba; Salomão, Reinaldo.

Afiliación

Santos SS; Division of Infectious Diseasses, Paulista School of Medicine, Federal University of Sao Paulo, Brazil.
Brunialti MKC; Division of Infectious Diseasses, Paulista School of Medicine, Federal University of Sao Paulo, Brazil.
Soriano FG; Laboratory of Medical Research, Faculty of Medicine of the University of São Paulo-USP, São Paulo, Brazil.
Szabo C; Chair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Salomão R; Division of Infectious Diseasses, Paulista School of Medicine, Federal University of Sao Paulo, Brazil.

Shock ; 56(6): 901-909, 2021 12 01.

Article en En | MEDLINE | ID: mdl-34115723

Asunto(s)

Inhibidores de Poli(ADP-Ribosa) Polimerasas/uso terapéutico; Sepsis/tratamiento farmacológico; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sepsis / Inhibidores de Poli(ADP-Ribosa) Polimerasas Límite: Humans Idioma: En Revista: Shock Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google